Blauvelt, A, Strober, BE, Eakin, GS, Howard, LM, Langan, C, van de Kerkhof, PCM, Puig, L, Lebwohl, MG, Romiti, R, Armstrong, AW, Choon, SE, Ramessur, R, Gelfand, JM, Merola, JF, Winthrop, KL, Torres, T. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; 94(3)DOI:10.1016/j.jaad.2025.11.033. PMID:41260526. IF:11.800(Q1/1D).

Garbayo-Salmons, P, Molina-Leyva, A, Porta-Vilaró, A, Soto-Moreno, A, Fornons-Servent, R, Gamissans, M, Garcias-Ladaria, J, Gracia-Darder, I, Martin-Ezquerra, G, Verdaguer-Faja, J, Mora-Fernández, V, Aguayo-Ortiz, RS, Vilarrasa, E, Masferrer, E, Corral-Magaña, O, Galvany, L, Rodrigo-Parés, A, Saus, E, Moreno, M, Carreras, A, Feliu-Hernàndez, C, Exposito-Serrano, V, Ribera, M, Sabat, M, Calvet, J. Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(4)DOI:10.1111/ijd.70125. PMID:41164894. IF:3.200(Q1/3D).

Krüger-Szabo, A, Ameen, A, Serra-Baldrich, E, Armstrong, AW, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2026; 24DOI:. PMID:. IF:3.800(Q1/2D).

Queiro-Silva, R, López-Ferrer, A, Farrés, MFI, Rivera-Díaz, R, Vidal-Sarro, D, Fernández-Freire, LR, de la Cueva-Dobao, P, Santos-Juanes, J, Rocamora-Duran, V, Gómez-Labrador, L, Belinchón-Romero, I. Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis. PLoS One. 2026; 21(3)DOI:10.1371/journal.pone.0342498. PMID:41770732. IF:2.600(Q2/4D).

Sánchez, TS, Giménez-Arnau, AM, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, Pérez, RG, González, IR, Mercader-García, P, Baldrich, ES, Carrillo, JMC, Romero, FT, De Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Navarro-Triviño, F, Chicharro, P, Nieto, MAP, de la Fuente, EG, Sánchez-Gilo, A, Andreu-Barasoain, M, Rodríguez, JJP, Ninot, GMI, Guillén, PS, Elosua-González, M, Grau-Pérez, M, Descalzo, MA, Borrego, L. Discordant Patch Test Reactions to 2-Bromo-2-Nitro-Propane-1,3-Diol (Bronopol): A Multicenter Study From REIDAC. CONTACT DERMATITIS. 2026; 94(4)DOI:10.1111/cod.70082. PMID:41456936. IF:4.600(Q1/1D).

Augustin, M, Feldman, SR, Warren, RB, Armstrong, A, Vender, R, López-Ferrer, A, Dawe, WH, Lambert, J, Szilagyi, B, Hoepken, B, Warham, R, Gottlieb, AB. Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis The BE RADIANT Randomized Clinical Trial With Open-Label Extension. JAMA Dermatology. 2026; 162(4)DOI:10.1001/jamadermatol.2025.6055. PMID:41706476. IF:11.000(Q1/1D).

Verdaguer-Faja, J, Ferrándiz-Pulido, C, Podlipnik, S, Guerra-Amor, A, Abril-Pérez, C, Estrada, RB, Masferrer, E, Lopez-Castillo, D, Deza, G, Leal, L, Marti-Marti, I, Ruiz-Salas, V, Yébenes, M, Martin, LM, Baliu, C, Castany, A, Boada, A, Toll, A, Jaka, A. Risk factors for close or involved margins in cutaneous squamous cell carcinoma of the scalp. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2026; 40(4)DOI:10.1111/jdv.20872. PMID:40709565. IF:8.000(Q1/1D).

Vilarrasa, E, Borrás-Blasco, J, Lobo-Benito, S, Loro-Pérez, M, Núñez-García, MG, Oliva-Moreno, J, Palacios-Martínez, D, Rubial-Bernárdez, F, Ivanova-Markova, Y, Daheron, M, Bellas, J, Martorell, A. Economic Burden of Hidradenitis Suppurativa in Spain. Dermatology and Therapy. 2026; 16(3)DOI:10.1007/s13555-026-01669-2. PMID:41723775. IF:4.200(Q1/1D).